Related Experiment Video
Updated: Oct 27, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Controlling Coagulation in Blood with Red Light
Patricia Müller1, Marlen Sahlbach1, Simone Gasper2
1Goethe University Frankfurt, Institute for Organic Chemistry and Chemical Biology, Max-von-Laue Str. 9, 60438, Frankfurt am Main, Germany.
Researchers developed a light-activated anticoagulant aptamer. Red light successfully deactivated the modified aptamer in human blood, restoring natural blood clotting capabilities.
Area of Science:
- Biochemistry
- Biotechnology
- Medical Chemistry
Background:
- Precise control over blood coagulation is critical in clinical settings.
- Rapid reversal of anticoagulation is often required for medical procedures.
- Existing methods for controlling anticoagulation may have limitations.
Purpose of the Study:
- To develop a novel anticoagulant aptamer with light-inducible deactivation.
- To enable precise temporal and spatial control over anticoagulation.
- To restore natural blood clotting capabilities rapidly using external stimuli.
Main Methods:
- Modification of a thrombin-binding aptamer using a red-light photocleavable linker (Cy7 derivative).
- Synthesis via copper-catalyzed Click chemistry.
- In vitro testing of aptamer deactivation and coagulation restoration in human blood using red light (660 nm).
Main Results:
- Successful synthesis of the modified thrombin-binding aptamer.
- Demonstration of aptamer deactivation upon exposure to red light (660 nm).
- Restoration of natural blood coagulation in human blood after light-induced aptamer inactivation.
Conclusions:
- A light-responsive anticoagulant aptamer was successfully engineered.
- Red light provides an effective external trigger for rapid anticoagulation reversal.
- This technology holds potential for precise control of anticoagulation in clinical applications.
Related Concept Videos
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

